// App-Quantinova.ai

TCT-624 : Clinical Outcomes with Everolimus-Eluting Stent for the Treatment of Cardiac Allograft Vasculopathy

Researchers

Presenter

  • Babak Azarbal

Principal Investigators

  • Boris Arbit

  • Radhakrishnan Ramaraj

  • David Chang

  • Jignesh Patel

  • Jon Kobashigawa

Medical Centers

  • Cedars-Sinai Medical Center, Hollywood, CA

  • Cedars-Sinai Heart Institute, Beverly Hills, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Cardiac allograft vasculopathy

  • Coronary Artery Disease

  • Myocardial infarction

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved